"hepatocellular carcinoma" trang 5 - tải miễn phí từ tailieunhanh
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
11    48    0
Imaging biomarkers for well and moderate hepatocellular carcinoma: Preoperative magnetic resonance image and histopathological correlation

Imaging biomarkers for well and moderate hepatocellular carcinoma: Preoperative magnetic resonance image and histopathological correlation
10    86    0
Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients

Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients
8    55    0
Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma

Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma
11    82    0
Functional consequences of enhanced expression of STIM1 and Orai1 in Huh-7 hepatocellular carcinoma tumor-initiating cells

Functional consequences of enhanced expression of STIM1 and Orai1 in Huh-7 hepatocellular carcinoma tumor-initiating cells
10    82    0
Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)

Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)
10    96    0
Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: A multi-center analysis

Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: A multi-center analysis
7    83    0
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
10    68    0
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
10    66    0
Gingival metastasis from primary hepatocellular carcinoma: A case report and literature review of 30 cases

Gingival metastasis from primary hepatocellular carcinoma: A case report and literature review of 30 cases
10    60    0
Paracrine effects of CCN3 from noncancerous hepatic cells increase signaling and progression of hepatocellular carcinoma

Paracrine effects of CCN3 from noncancerous hepatic cells increase signaling and progression of hepatocellular carcinoma
10    92    0
Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
9    73    0
Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: A multicenter randomized double-blind controlled trial (SOMAPROTECT)

Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: A multicenter randomized double-blind controlled trial (SOMAPROTECT)
9    97    0
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intraarterial therapies

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intraarterial therapies
9    74    0
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma

Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma
9    43    0
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
10    58    0
Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma

Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
10    53    0
Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
11    42    0
The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma

The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma
9    56    0
Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
9    87    0